REPLIGEN CORP - COMMON STOCK (RGEN)

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
56,788,855
Share change
+2,234,720
Total reported value
$9,027,253,663
Put/Call ratio
90%
Price per share
$159.01
Number of holders
430
Value change
+$368,155,521
Number of buys
204
Number of sells
214

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2023

As of 30 Sep 2023, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 430 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,788,855 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, STATE STREET CORP, SANDS CAPITAL MANAGEMENT, LLC, Artisan Partners Limited Partnership, BROWN CAPITAL MANAGEMENT LLC, WELLINGTON MANAGEMENT GROUP LLP, and MACQUARIE GROUP LTD. This page lists 434 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.